Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.94 USD | +2.80% | +7.89% | +48.14% |
30/04 | Enanta Pharmaceuticals, Inc. Appoints Matthew P. Kowalsky as Chief Legal Officer | CI |
09/02 | Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $17 From $21, Maintains Perform Rating | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- ENTA Stock
- News Enanta Pharmaceuticals, Inc.
- Official Publications